Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study

Detalles Bibliográficos
Autores principales: Combe, Bernard G., Tanaka, Yoshiya, Buch, Maya H., Nash, Peter, Burmester, Gerd R., Kivitz, Alan J., Bartok, Beatrix, Pechonkina, Alena, Xia, Katrina, Emoto, Kahaku, Kano, Shungo, Hendrikx, Thijs K., Landewé, Robert B. M., Aletaha, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931971/
https://www.ncbi.nlm.nih.gov/pubmed/36598735
http://dx.doi.org/10.1007/s40744-022-00530-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931971/
https://www.ncbi.nlm.nih.gov/pubmed/36598735
http://dx.doi.org/10.1007/s40744-022-00530-0

Ejemplares similares